Effects of 4 Weeks Recombinant Human Growth Hormone Administration on Insulin Resistance of Skeletal Muscle in Rats

키워드

참고문헌 (48)

1. Doga M, "Growth hormone deficiency in the adult", Pituitary, 9, pp.305~311 (2006)
2. Henwood MJ, "Expanded spectrum of recombinant human growth hormone therapy", Curr Opin Pediatr, 14, pp.437~442 (2002)
3. Woodhouse LJ, "The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults", Endocr Rev, 27, pp.287~317 (2006)
4. Bramnert M, "Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle", J Clin Endocrinol Metab, 88, pp.1455~1463 (2003)
5. Cartee GD, "Growth hormone reduces glucose transport but not GLUT-1 or GLUT-4 in adult and old rats", Am J Physiol, 268(5pt1), pp.E902~E909 (1995)
6. Chrisoulidou A, "Effects of 7 years of growth hormone replacement therapy in hypopituitary adults", J Clin Endocrinol Metab, 85, pp.3762~3769 (2000)
7. Groop L, "Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment", Horm Res, 64(3), pp.45~50 (2005)
8. Ng SF, "Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in vivo", Metabolism, 39, pp.264~268 (1990)
9. Yuen KC, "Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults", Growth Horm IGF Res, 16(A), pp.S55~S61 (2006)
10. Hou CW, "Interactive effect of exercise training and growth hormone administration on glucose tolerance and muscle GLUT4 protein expression in rats", J Biomed Sci, 10(6P)통권 : T2, pp.689~696 (2003)
11. Riddick FA Jr, "The sugar transport system in striated muscle. Effect of growth hormone, hydrocortisone and alloxan diabetes", Diabetes, 11, pp.171~178 (1962)
12. Binnerts A, "The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition", Clin Endocrinol (Oxf), 37, pp.79~87 (1992)
13. Ivy JL, "Prevention and treatment of non-insulin-dependent diabetes mellitus", Exerc Sport Sci Rev, 27, pp.1~35 (1999)
14. Jørgensen JO, "Growth hormone and glucose homeostasis", Horm Res, 62(3), pp.51~55 (2004)
15. Kim JK, "Acute effect of growth hormone to induce peripheral insulin resistance is independent of FFA and insulin levels in rats", Am J Physiol, 277(4 PT 1), pp.E742~E749 (1999)
16. Møller N, "Effects of growth hormone on lipid metabolism in humans", Growth Horm IGF Res, 13(A), pp.S18~S21 (2003)
17. Zisman A, "Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance", Nat Med, 6, pp.924~928 (2000)
18. Hegarty BD, "Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats", Diabetes, 51, pp.1477~1484 (2002)
19. Pan DA, "Skeletal muscle triglyceride levels are inversely related to insulin action", Diabetes, 46, pp.983~988 (1997)
20. Kawano Y, "Changes in glucose transport and protein kinase Cbeta(2) in rat skeletal muscle induced by hyperglycaemia", Diabetologia, 42, pp.1071~1079 (1999)
21. Young JC, "Role of dihydropyridine sensitive calcium channels in glucose transport in skeletal muscle", Life Sci, 61, pp.335~342 (1997)
22. Bielawska A, "Determination of ceramides and diglycerides by the diglyceride kinase assay", Anal Biochem, 298, pp.141~150 (2001)
23. Burton AF, "Increased cholesteryl ester content in liver of mice fed lipid emulsion diets high in polyunsaturated fats", JPEN J Parenter Enteral Nutr, 9, pp.480~482 (1985)
24. Morgan CR, "Immunoassay of insulin using a two-antibody system", Proc Soc Exp Biol Med, 110, pp.29~32 (1962)
25. "Rinsho Byori", 1973, 457~460
26. Virkamäki A, "Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle", Diabetes, 50, pp.2337~2343 (2001)
27. Summers SA, "Ceramides in insulin resistance and lipotoxicity", Prog Lipid Res, 45, pp.42~72 (2006)
28. Summers SA, "Regulation of insulin-stimulated glucose transporter GLUT4translocation and Akt kinase activity by ceramide", Mol Cell Biol, 18, pp.5457~5464 (1998)
29. Straczkowski M, "Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes", Diabetologia, 50, pp.2366~2373 (2007)
30. Schmitz-Peiffer C, "Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate", J Biol Chem, 274, pp.24202~24210 (1999)
31. Krag MB, "Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics", Am J Physiol Endocrinol Metab, 292, pp.E920~E927 (2007)
32. Segerlantz M, "Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults", Eur J Endocrinol, 149, pp.511~519 (2003)
33. Adiels M, "Overproduction of large VLDL particles is driven by increased liver fat content in man", Diabetologia, 49, pp.755~765 (2006)
34. Boden G, "Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction", Eur J Clin Invest, 32(3), pp.14~23 (2002)
35. McGarry JD, "Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes", Diabetes, 51, pp.7~18 (2002)
36. Johansen T, "Growth hormone-mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets", Horm Metab Res, 35, pp.243~250 (2003)
37. Yip RG, "Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi alpha2 to lower density membrane fractions", Endocrinology, 140, pp.1219~1227 (1999)
38. Louveau I, "Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system", Domest Anim Endocrinol, 27, pp.241~255 (2004)
39. Richelsen B, "Effect of growth hormone on adipose tissue and skeletal muscle lipoprotein lipase activity in humans", J Endocrinol Invest, 22(5), pp.10~15 (1999)
40. Randle PJ, "The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus", Lancet, 1, pp.785~789 (1963)
41. Cartee GD, "What insights into age-related changes in skeletal muscle are provided by animal models?", J Gerontol A Biol Sci Med Sci, 50, pp.137~141 (1995)
42. Christopher M, "Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy", J Clin Endocrinol Metab, 83, pp.1668~1681 (1998)
43. Jessen N, "Evidence against a role for insulinsignaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by shortterm GH infusion", Am J Physiol Endocrinol Metab, 288, pp.E194~E199 (2005)
44. Boden G, "Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes", Exp Clin Endocrinol Diabetes, 111, pp.121~124 (2003)
45. Goodpaster BH, "Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus", Am J Clin Nutr, 71, pp.885~892 (2000)
46. Stannard SR, "Insulin resistance and elevated triglyceride in muscle: more important for survival than "thrifty" genes?", J Physiol, 554(PT 3), pp.595~607 (2004)
47. Hegarty BD, "The role of intramuscular lipid in insulin resistance", Acta Physiol Scand, 178, pp.373~383 (2003)
48. Henriksen EJ, "Glucose transporter protein content and glucose transport capacity in rat skeletal muscles", Am J Physiol, 259(4PT 1), pp.E593~E598 (1990)

관련 논문AI추천